Opinion

Video

Patient Monitoring Strategies in BCG-Unresponsive NMIBC

Author(s):

Gordon A. Brown, DO,Siamak Daneshmand, MD

Bladder cancer specialists discuss their strategies for monitoring patients with BCG-unresponsive non–muscle invasive bladder cancer.

Related Videos
4 experts in this video
Rebecca A. Campbell, MD, answers a question during a Zoom video interview
Joshua J. Meeks, MD, PhD, gives an answer during a Zoom video interview
Joshua J. Meeks, MD, PhD, answers a question during a Zoom video interview
Related Content
Urologic surgeons successfully complete world’s first bladder transplant
May 19th 2025

Urologic surgeons successfully complete world’s first bladder transplant

Hannah Clarke
The bladder transplant procedure involved a collaboration between the University of California, Los Angeles and the University of Southern California.
medical depiction of bladder cancer
May 31st 2023

Bladder Cancer Awareness Month: Dr. Kamat highlights the state of bladder cancer care

Urology Times staff
In this episode, Ashish M. Kamat, MD, MBBS, highlights the state of bladder cancer care in recognition of Bladder Cancer Awareness Month.
Disitamab vedotin plus toripalimab extends PFS, OS in HER2-positive la/mUC
May 12th 2025

Disitamab vedotin plus toripalimab extends PFS, OS in HER2-positive la/mUC

Hannah Clarke
The phase 3 RC48-C016 trial met its primary end points.
Dr. Lutz on sexual dysfunction, performance anxiety, and Peyronie's disease
May 26th 2022

Dr. Lutz on sexual dysfunction, performance anxiety, and Peyronie's disease

Urology Times staff
“We know that erectile dysfunction is really an important issue that can be a harbinger for other underlying cardiovascular or neurological health issues,” says Michael Lutz, MD.
Physical function and frailty measures offer distinct insights in patients with bladder cancer
May 7th 2025

Physical function and frailty measures offer distinct insights in patients with bladder cancer

Hannah Clarke
Data showed that physical function and self-reported frailty assessments were poorly correlated.
FDA to host advisory committee meeting on UGN-102 for NMIBC
May 7th 2025

FDA to host advisory committee meeting on UGN-102 for NMIBC

Hannah Clarke
The Oncologic Drugs Advisory Committee meeting is scheduled for May 21, 2025.
© 2025 MJH Life Sciences

All rights reserved.